William M Carrera, MD
Ophthalmology · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 3 carriers
- Office
- 1
- Since medical school
- 9 years
- Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University, 2017
Offices
1 location · East Bay Retina Consultants A Medical Group Inc · 6 clinicians in this group
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plans that list them
16 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Carrera’s office at (510) 444-1600 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$162,266
Medicare paid this office $162,266 for 404 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, aflibercept, 1 mg | 12 | $21,974 | None |
| New patient visit (45+ min) | 122 | $18,881 | $155 |
| Imaging of retina | 267 | $15,010 | $40 |
| Injection of drug into eye | 65 | $11,559 | $114 |
| Established patient problem focused exam of visual system | 90 | $10,730 | $89 |
See all 16 services
| Injection, aflibercept, 1 mg | 12 | $21,974 | None |
| New patient visit (45+ min) | 122 | $18,881 | $155 |
| Imaging of retina | 267 | $15,010 | $40 |
| Injection of drug into eye | 65 | $11,559 | $114 |
| Established patient problem focused exam of visual system | 90 | $10,730 | $89 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 28 | $6,189 | $213 |
| Repair of detached retina with drainage and removal of eye fluid between lens and retina | 19 | $6,098 | $305 |
| New patient visit (60+ min) | 31 | $5,951 | $192 |
| Established patient complete exam of visual system | 41 | $4,844 | $118 |
| Removal of eye fluid (vitreous) between lens and retina | 28 | $4,791 | $171 |
| Compounded drug, not otherwise classified | 43 | $4,790 | None |
| Extended exam of the back part of the eye with optic nerve drawing | 178 | $2,964 | $14 |
| Return visit (30+ min) | 13 | $1,592 | $122 |
| New patient complete exam of visual system | 11 | $1,482 | $135 |
| Extended exam of the back part of the eye with retinal drawing | 38 | $1,008 | $23 |
| Imaging of retina | 34 | $560 | $16 |
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Procedures year by year
| Procedure | 2022 | 2023 | 2024 |
|---|---|---|---|
| Injection of drug into eye | 11 | 20 | 101 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | – | 44 | 29 |
| Removal of eye fluid (vitreous) between lens and retina | – | 32 | 28 |
| Repair of detached retina with drainage and removal of eye fluid between lens and retina | – | 19 | 20 |
| Complex repair of detached retina and drainage of eye fluid between lens and retina | – | 21 | – |
| Removal of membrane of retina | – | 19 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
404 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 12% · Women 57% · Also on Medicaid 19% · Health risk score 1.19. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 73% · Diabetes 31% · Coronary heart disease 22% · Chronic kidney disease 22% · Depression 17% · Cancer 15% · Atrial fibrillation 14% · Heart failure 11% · COPD 10% · Stroke 7% · Dementia 3%.
The office billed $542,286, Medicare allowed $206,237 and paid $162,266; for 1,846 services of 44 kinds; $49,680 of it was for drugs given in the office and $112,586 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 404 | 1,846 | 75 | 1.19 | $542,286 | $162,266 |
| 2023 | 309 | 374 | 75 | 1.24 | $245,940 | $35,950 |
| 2022 | 104 | 148 | 75 | 1.57 | $54,183 | $9,355 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Removal of membrane of retina with removal of internal limiting membrane of retina | 44 | $6,668 | $152 |
| Removal of eye fluid (vitreous) between lens and retina | 32 | $3,833 | $120 |
| Complex repair of detached retina and drainage of eye fluid between lens and retina | 20 | $3,806 | $181 |
| Repair of detached retina with drainage and removal of eye fluid between lens and retina | 18 | $3,050 | $161 |
| Removal of membrane of retina | 19 | $2,967 | $156 |
| Imaging of retina | 99 | $2,084 | $20 |
| Injection of drug into eye | 19 | $1,656 | $83 |
| Short return visit (20+ min) | 29 | $1,655 | $53 |
| Photography of the retina | 11 | $180 | $16 |
2022: 5 services
| Established patient complete exam of visual system | 26 | $1,726 | $66 |
| Short return visit (20+ min) | 19 | $1,087 | $57 |
| Injection of drug into eye | 11 | $1,072 | $97 |
| Imaging of retina | 38 | $830 | $22 |
| Established patient problem focused exam of visual system | 14 | $617 | $44 |
Medicaid work
$14,074 in 2024
Medicaid paid $14,074 for 346 billed services this clinician did in 2024, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 61 | $5,638 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 33 | $4,418 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 155 | $2,968 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 33 | $589 |
| Bilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report | 64 | $461 |
| 2024 | 346 | 5 | 42 | $14,074 |
| 2023 | 93 | 1 | 32 | $693 |
| 2022 | 47 | 2 | 18 | $1,111 |
See the largest Medicaid services in earlier years
2023
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 93 | $693 |
2022
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 27 | $874 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 20 | $237 |
Drugs they prescribed that Part D paid
$20,336
Pharmacies billed $20,336 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 190) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
97 generic and 93 brand-name prescriptions · $20,336 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 13 | $8,445 | $650 |
| Bromfenac | 12 | $2,972 | $248 |
| Prednisolone Acetate | 51 | $2,073 | $41 |
| Ketorolac Tromethamine | 15 | $555 | $37 |
| Ofloxacin | 14 | $169 | $12 |
See all 7 drugs
| Restasis | 13 | $8,445 | $650 |
| Bromfenac | 12 | $2,972 | $248 |
| Prednisolone Acetate | 51 | $2,073 | $41 |
| Ketorolac Tromethamine | 15 | $555 | $37 |
| Ofloxacin | 14 | $169 | $12 |
| Dorzolamide-Timolol | 14 | $117 | $8 |
| Latanoprost | 19 | $92 | $5 |
Year by year
| 2024 | 190 | 76 | 0% (0) | 49% | $20,336 |
| 2023 | 358 | 151 | 0% (0) | 49% | $36,635 |
| 2022 | 171 | 82 | 0% (0) | 43% | $15,837 |
| 2021 | 161 | 81 | 0% (0) | 37% | $10,233 |
| 2018 | 45 | 15 | None | None | $675 |
| 2017 | 26 | 15 | None | None | $582 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Prolensa | 21 | $8,820 | $420 |
| Prednisolone Acetate | 141 | $8,239 | $58 |
| Ofloxacin | 55 | $751 | $14 |
| Brimonidine | 11 | $674 | $61 |
| Ketorolac Tromethamine | 25 | $533 | $21 |
| Polymyxin B Sul-Trimethoprim | 27 | $230 | $9 |
| Latanoprost | 13 | $91 | $7 |
2022: 6 drugs
| Prolensa | 15 | $5,315 | $354 |
| Prednisolone Acetate | 45 | $2,775 | $62 |
| Ofloxacin | 17 | $257 | $15 |
| Dorzolamide-Timolol | 12 | $250 | $21 |
| Brimonidine | 15 | $187 | $12 |
| Polymyxin B Sul-Trimethoprim | 17 | $125 | $7 |
2021: 3 drugs
| Prednisolone Acetate | 44 | $3,887 | $88 |
| Erythromycin | 25 | $336 | $13 |
| Latanoprost | 13 | $209 | $16 |
Money from drug and device companies
$6,637 in 2025
| 2025 | 4 | 9 | $5,655 | $6,637 |
| 2024 | 6 | 9 | None | $521 |
| 2023 | 4 | 9 | None | $1,101 |
| 2022 | 3 | 3 | None | $218 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genentech USA | Vabysmo | $6,534 | 6 payments
|
| Regeneron Pharmaceuticals | Eylea Hd | $54 | 1 payment
|
| ANI Pharmaceuticals | Yutiq | $31 | 1 payment
|
| Astellas Pharma US | Izervay | $18 | 1 payment
|
See all 9 published payments
| Genentech USA | Consulting · 2025-10-16 | Vabysmo | $5,655 |
| Genentech USA | Travel · 2025-10-16 | Vabysmo | $505 |
| Genentech USA | Meals · 2025-10-16 | Vabysmo | $286 |
| Genentech USA | Meals · 2025-10-09 | Vabysmo | $29 |
| Regeneron Pharmaceuticals | Meals · 2025-09-11 | Eylea Hd | $54 |
| Genentech USA | Meals · 2025-08-14 | Vabysmo | $33 |
| ANI Pharmaceuticals | Meals · 2025-07-10 | Yutiq | $31 |
| Genentech USA | Meals · 2025-03-20 | Vabysmo | $26 |
| Astellas Pharma US | Meals · 2025-01-13 | Izervay | $18 |
See earlier years (2024, 2023, 2022)
2024: $521
| Genentech USA | Vabysmo | $189 | 3 payments
|
| Apellis Pharmaceuticals | Syfovre | $188 | 2 payments
|
| Regeneron Pharmaceuticals | Eylea Hd | $44 | 1 payment
|
| Alimera Sciences | Yutiq | $41 | 1 payment
|
| Astellas Pharma US | Izervay | $33 | 1 payment
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $26 | 1 payment
|
2023: $1,101
| Alcon Vision | Constellation | $579 | 5 payments
|
| Regeneron Pharmaceuticals | Eylea Hd | $265 | 2 payments
|
| Genentech USA | Vabysmo | $140 | 1 payment
|
| Abbvie | Ozurdex | $117 | 1 payment
|
2022: $218
| Regeneron Healthcare Solutions | Eylea | $112 | 1 payment
|
| Apellis Pharmaceuticals | None | $82 | 1 payment
|
| Alcon Vision | Centurion | $23 | 1 payment
|
Professional record
- NPI
- 1679014013
- Trained
- Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University, 2017 · 9 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X); Federal specialty code 207WX0107X (207WX0107X)
- Mailing address
- 3300 Telegraph Ave, Oakland, CA, 94609
- NPI first listed
- 2017-03-18
- NPI last updated
- 2024-07-16
- NPI record certified
- 2024-07-16
This is when the NPI record was last certified, not a medical board exam.